United Therapeutics Corporation (UTHR)
Payables turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 309,700 | 257,500 | 146,700 | 122,500 | 108,100 |
Payables | US$ in thousands | — | — | — | — | — |
Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $309,700K ÷ $—K
= —
The payables turnover ratio for United Therapeutics Corporation is not provided for the years ending December 31, 2020, 2021, 2022, 2023, and 2024. The lack of data for this ratio makes it challenging to assess the efficiency with which the company is managing its accounts payable in relation to its purchases. It is recommended to track this ratio in the future to better understand the company's payment practices and liquidity management.
Peer comparison
Dec 31, 2024
Company name
Symbol
Payables turnover
United Therapeutics Corporation
UTHR
—
Abbott Laboratories
ABT
—
AbbVie Inc
ABBV
—
ACADIA Pharmaceuticals Inc
ACAD
—
Alkermes Plc
ALKS
19.54
Amphastar P
AMPH
11.74
ANI Pharmaceuticals Inc
ANIP
—
Arcus Biosciences Inc
RCUS
8.33
Biomarin Pharmaceutical Inc
BMRN
—
Bristol-Myers Squibb Company
BMY
8.82
Catalyst Pharmaceuticals Inc
CPRX
—